Abstract
The study aims to clarify the relation between chemosensitivity and HtrA1 expression, and the possible way HtrA1 works. Drug-resistant cell line HepG2/ADM was induced by increasing adriamycin (ADM), and eukaryotic expression vector pEGFP-N1-HtrA1 was constructed using BamHI and EcoRI restriction enzymes, after which, HepG2/ADM was transfected with pEGFP-N1-HtrA1. Resistance index (RI) of the hepatoma cell lines to different anti-cancer drugs (ADM, 5-Fu, MMC, L-OHP and VCR) was determined by MTT assay before and after HtrA1 high expression. After an HtrA1 inhibitor, NVP-LEB748 was adopted in the HtrA1 overexpressing cells, expression of proteins P-gp, MRP and XIAP (X-linked inhibitor of apoptosis protein) in HepG2/ADM cells were analyzed by western blot, and the activities of caspases 3, 7 and 9 were respectively measured using activity assay kits. The results showed that RI was negatively correlated with the expression of HtrA1, upregulated XIAP expression was resulted from the HtrA1 inhibitor, and variance of activities of caspases 3, 7 and 9 were remarkably descended with its increasing concentration. It was concluded that high expression of HtrA1 could significantly reverse multidrug resistance of hepatoma cells by targeting...Continue Reading
References
Jan 18, 1995·Journal of the National Cancer Institute·S SelaA Rahman
Dec 2, 1996·FEBS Letters·J Zumbrunn, B Trueb
Aug 10, 2000·The Journal of Biological Chemistry·C SunS W Fesik
Aug 17, 2000·Journal of the National Cancer Institute·P BorstJ Wijnholds
Nov 28, 2002·International Journal of Cancer. Journal International Du Cancer·Vladimir BilimYoshihiko Tomita
Sep 23, 2003·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Antonio De LucaAlfonso Baldi
Jan 13, 2004·Oncogene·Jeremy ChienViji Shridhar
May 6, 2005·Cancer Chemotherapy and Pharmacology·Ting-Chao ChouDale L Boger
Jun 13, 2006·The Journal of Clinical Investigation·Jeremy ChienViji Shridhar
Nov 28, 2006·Journal of Chemotherapy·Jun ChenGui-Yuan Li
Aug 16, 2008·Cancer Letters·Li Hua ZhengYu Xin Li
Oct 18, 2008·Expert Review of Anticancer Therapy·Maria PleguezueloAndrew K Burroughs
May 28, 2009·Molecular and Cellular Biology·Jeremy ChienViji Shridhar
Aug 14, 2009·Expert Review of Gastroenterology & Hepatology·Mohamed I F ShariffSimon D Taylor-Robinson
May 18, 2010·Expert Opinion on Therapeutic Targets·Dorota Zurawa-JanickaBarbara Lipinska
Mar 10, 2011·International Journal of Cancer. Journal International Du Cancer·Xiaoping HeViji Shridhar
Mar 31, 2011·Histopathology·Vincenzo CatalanoAlfonso Baldi
Oct 12, 2012·European Journal of Pharmacology·Hengrui ZhuLong Yu
Oct 20, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jin XiaQingxia Fan
Citations
Dec 2, 2015·Oncology Letters·Xiu-Li ZhuLian-Mei Zhao
Sep 25, 2019·Cells·Tomasz WentaBarbara Lipinska
Aug 11, 2020·The Journal of International Medical Research·Yachun LiWanzhong Yin
Apr 2, 2016·International Journal of Molecular Medicine·Ying-Jie YiShu-Yang Xie
May 23, 2017·Oncology Letters·Xin-Hong WangBing Du
Nov 30, 2018·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·Hao ChengYiming Pan
Dec 24, 2019·Cell Proliferation·Yihe LiJiake Xu
Nov 4, 2020·Biomolecules·Huailu Tu, Max Costa
Jul 11, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Liangliang WuWeiwei Tang